Drug Shortage Report for PROCYTOX
Report ID | 225670 |
Drug Identification Number | 02241800 |
Brand name | PROCYTOX |
Common or Proper name | Procytox |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | CYCLOPHOSPHAMIDE |
Strength(s) | 2000MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 2G |
ATC code | L01AA |
ATC description | ALKYLATINGAGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2024-04-19 |
Actual start date | 2024-04-19 |
Estimated end date | 2024-05-06 |
Actual end date | 2024-05-02 |
Shortage status | Resolved |
Updated date | 2024-05-03 |
Company comments | Release expected April 25th, 2024 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-05-03 | English | Compare |
v7 | 2024-05-02 | French | Compare |
v6 | 2024-05-02 | English | Compare |
v5 | 2024-04-26 | French | Compare |
v4 | 2024-04-26 | English | Compare |
v3 | 2024-04-20 | English | Compare |
v2 | 2024-04-19 | French | Compare |
v1 | 2024-04-19 | English | Compare |
Showing 1 to 8 of 8